Recently, according to "Wall Street Journal" and other financial media reports, the US blood test company Theranos received a new financing of 100 million US dollars, the investor is Fortress Investment Group (hereinafter referred to as Fortress), "Fortune" magazine teased: "can be called a Christmas miracle Although it is more unusual and arrogant." Once the darling of Silicon Valley, Theranos promised that they could quickly get comprehensive blood testing technology by taking a few drops of blood from a pricked finger, including more than 240 tests, from cholesterol to cancer, October 2015, The Wall Street Journal reveals its existence and falsification. According to the former employee who has left the company, Edison can detect up to 240 kinds of indicators (such as high cholesterol and cancer) through a few blood tests. Edison can only detect 15 kinds of tests, and the test results There are also big problems in reliability and accuracy, and more indicators are actually obtained through the detection of mature equipment on the market. Theranos began to walk down the altar step by step, and is on the brink of extinction. At the same time, David Boies, a lawyer with Theranos, said that Theranos did not test all of the blood tests it advertised on Edison equipment, but only on the road to this goal, followed by CMS's business related to Theranos. In-depth investigations have further accelerated the rhythm of the Theranos building. The results of the CMS survey showed that Thereranus had a large number of defects in the operation process and test results, and proposed six penalties for Theranos, including the suspension of the California laboratory license. Although Theranos made certain remedies for these problems, the results still could not Convince the public. After that, Theranos was also hit by a series of blows. CMS banned Theranos founder Elizabeth Holmes from owning or operating a clinical laboratory for two years. Several investors and former partners started the fraud and the group of Theranos. The lawsuit and the US Securities and Exchange Commission are also investigating Theranos. Currently, Theranos focuses on miniLab technology, which was launched last August, and Elizabeth Holmes said it is part of Theranos' “decentralization†lab program, which means users don't need to send test samples to physical labs. , you can test. However, miniLab also requires FDA approval. From the current point of view, the listing of miniLab is nowhere in sight. For example, the continuous oscillating effect of dominoes has cast a strong shadow on Theranos's business structure and funding sources. No investment company is willing to add more codes. In order to save money, Theranos has already laid off a large number of employees. And moved the headquarters to relocate all of its employees and operations from Palo Alto, Calif., to a factory near Newark. Therefore, this Fortune's $100 million new financing can be described as “selling in the snowâ€, but charcoal is not a white one. The Fortress will receive a 4% stake in Theranos, and the loan from Fortress will be secured by the patent of Theranos. It is understood that Fortress is a US asset management company, investment in non-performing assets is one of its expertise, in February this year, Japan Softbank Group announced the acquisition of Fortress for about $3.3 billion in cash. Infusion set,Disposable Syringe,Insulin Syringe,gauze roll,Cotton roll,Sterile Urine cup FOSHAN PHARMA CO., LTD. , https://www.fspharmaapi.com